论文部分内容阅读
目的探讨获得性支原体肺炎最有效的治疗方法。方法选择我院2009年4月至2009年6月呼吸内科接收的某社区支原体肺炎患者116例,随机分为A组与B组,A组给予阿奇霉素10 mg/kg+维生素K110 mg+0.9%生理盐水静脉点滴,B组给予红霉素+0.9%生理盐水100～250 ml静脉点滴,观察两组患者的治疗效果与副作用发生率。结果 A组的治疗总有效率明显高于B组,且副作用发生率明显少于B组,P<0.05,差异有统计学意义。结论阿奇霉素加维生素K1治疗获得性支原体肺炎疗效确切,且副作用少,可作为治疗支原体肺炎的首选药物。
Objective To investigate the most effective treatment for acquired mycoplasmal pneumonia. Methods One hundred and sixty-six patients with mycoplasmal pneumonia received in our hospital from April 2009 to June 2009 were randomly divided into A group and B group. A group received azithromycin 10 mg / kg + vitamin K110 mg + 0.9% saline Intravenous drip, B group were given erythromycin + 0.9% saline 100 ~ 250 ml intravenous drip to observe the two groups of patients with treatment and side effects. Results The total effective rate in group A was significantly higher than that in group B, and the incidence of side effects was significantly less than that in group B (P <0.05). The difference was statistically significant. Conclusion Azithromycin plus vitamin K1 treatment of acquired mycoplasma pneumonia is effective and less side effects, can be used as the treatment of mycoplasma pneumonia drug of choice.